In SCD specimens the treatment with AnkT9W ameliorates erythropoiesis by increasing adult hemoglobin (Hb A) and concurrently reducing the sickling tetramer (Hb S). This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.